Aline Sprikkelman

and 3 more

Background: Eczema in early childhood is associated with developing subsequent allergic diseases, including food allergy, asthma and hay fever. However, eczema has a heterogenous presentation regarding age of onset and persistence, which may lead to different allergic outcomes during childhood/adolescence. Recently, sub-phenotypes of eczema have been suggested as predictor for allergic multimorbidity. Objective: To identify associations of eczema phenotypes with food allergy, asthma and hay fever during childhood/adolescence. Additionally, we aimed to describe the trajectories of eczema, asthma and hay fever, stratifying by food allergy presence. Methods: TRACKER (Trajectories of Allergy in Children in Real Life Databases) is a prospective cross-sectional population-based cohort study of 6,852 children/adolescents from the Lifelines cohort. We investigated associations of seven eczema phenotypes, based on age of onset and persistence, with food allergy, asthma and hay fever using logistic regression, adjusted for appropriate covariates. Disease trajectories were determined by calculating prevalence at different ages. Results: Participants who suffered from eczema throughout childhood showed higher risks of developing food allergy, hay fever and asthma. “Very early onset – persistent” eczema showed the strongest associations with food allergy, asthma and hay fever. The prevalence of eczema, asthma and hay fever at all ages were significantly higher in participants with food allergy, compared to those without. Conclusion: The largest cohort study on this topic to date shows that (very) early onset and persistent eczema increases the risk for allergic multimorbidity. Identification of infants at risk for developing (very) early onset eczema is of utmost importance to prevent allergic multimorbidity.

Cancan Qi

and 9 more

Background: Asthma is a chronic respiratory disease which is not curable, yet some patients experience spontaneous remission. We hypothesized that epigenetic mechanisms may be involved in asthma remission. Methods: Clinical remission (ClinR) was defined as the absence of asthma symptoms and medication for at least 12 months, and complete remission (ComR) was defined as ClinR with normal lung function and absence of airway hyperresponsiveness. We analyzed differential DNA methylation of ClinR and ComR comparing to persistent asthma (PersA) in whole blood samples (n=72) and nasal brushing samples (n=97) in a longitudinal cohort of well characterized asthma patients. Significant findings of whole blood DNA methylation were tested for replication in two independent cohorts, Lifelines and EGEA. Results: We identified differentially methylated CpG sites associated with ClinR (7 CpG sites) and ComR (129 CpG sites) in whole blood. One CpG (cg13378519, Chr1) associated with ClinR was replicated and annotated to PEX11 (Peroxisomal Biogenesis Factor 11 Beta). The whole blood DNA methylation levels of this CpG were also different between ClinR and healthy subjects. One ComR-associated CpG (cg24788483, Chr10) that annotated to TCF7L2 (Transcription Factor 7 Like 2) was replicated and associated with expression of TCF7L2 gene. One out of seven ClinR-associated CpG sites and 8 out of 129 ComR-associated CpG sites identified from whole blood samples showed nominal significance (P<0.05) and the same direction of effect in nasal brushes. Conclusion: We identified DNA methylation markers possibly associated with clinical and complete asthma remission in nasal brushes and whole blood.